Advanced search
Publication Cover
Modern Rheumatology Volume 24, 2014 - Issue 1
Journal homepage
124
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus

Yuki ShimadaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
,
Yu Funakubo AsanumaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, JapanCorrespondence[email protected]
,
Kazuhiro YokotaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
,
Yoshihiro YoshidaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
,
Hiroshi KajiyamaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
,
Kojiro SatoDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
,
Yuji AkiyamaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
&
Toshihide MimuraDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
 show all
Pages 78-85 | Received 10 Oct 2012, Accepted 28 Dec 2012, Published online: 22 Nov 2013

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Yu Funakubo Asanuma, Yoshimi Aizaki, Hisashi Noma, Kazuhiro Yokota, Mayumi Matsuda, Noritsune Kozu, Yoshitake Takebayashi, Hiroshi Nakatani, Tomoko Hasunuma, Shinichi Kawai & Toshihide Mimura. (2020) Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study. Modern Rheumatology 30:6, pages 959-966.
Read now
Renato Nisihara, Thelma L. Skare, João Otávio Zeni, Henrique Rasera, Karita Lidani & Iara Messias-Reason. (2018) Plasma levels of pentraxin 3 in patients with spondyloarthritis. Biomarkers 23:1, pages 14-17.
Read now
Mo Yuan, Ying Tan, Yun Pang, Yong-zhe Li, Yan Song, Feng Yu & Ming-hui Zhao. (2017) Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study. Renal Failure 39:1, pages 465-473.
Read now
Paweł Cieślik & Antoni Hrycek. (2015) Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus. Autoimmunity 48:4, pages 242-250.
Read now

Articles from other publishers (26)

M Fornaro, F Girolamo, F Cacciapaglia, G Carabellese, R Bizzoca, C Scioscia, L Coladonato, G Lopalco, M Ruggieri, M Mastrapasqua, G Fari, D D’Abbicco & F Iannone. (2023) Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity. Clinical and Experimental Immunology 214:1, pages 94-102.
Crossref
Yongzhen Li, Shouzan Zhang, Jingqi Liu, Yudi Zhang, Nan Zhang, Quan Cheng, Hao Zhang & Xiaochuan Wu. (2023) The pentraxin family in autoimmune disease. Clinica Chimica Acta 551, pages 117592.
Crossref
Sahar A. Ismail, Sara M. Awad, Rania M. Gamal, Marwa A. Gaber, Safaa M. Hussein & Nevin Hammam. (2023) Serum pentraxin 3 in systemic lupus erythematosus: A potential indicator of cutaneous disease activity. Lupus 32:7, pages 873-879.
Crossref
S. C. Bergkamp, M. J. Wahadat, A. Salah, T. W. Kuijpers, V. Smith, S. W. Tas, J. M. van den Berg, S. Kamphuis & D. Schonenberg-Meinema. (2023) Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis. Journal of Inflammation 20:1.
Crossref
Hao Zhang, Ruixuan Wang, Zeyu Wang, Wantao Wu, Nan Zhang, Longbo Zhang, Jason Hu, Peng Luo, Jian Zhang, Zaoqu Liu, Songshan Feng, Yun Peng, Zhengzheng Liu & Quan Cheng. (2022) Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role. Biomedicine & Pharmacotherapy 156, pages 113783.
Crossref
Eman G. Behiry, Howyda M. Kamal, Anas A. Rahman, Hesham A. Eissa, Waleed A. Hassan, Zainab G. Hassan, Marian M. Shafeek & Asmaa A. El-Fallah. (2020) Association of genetic variants of interleukin-1β gene -511T/C (rs16944) and +3954C/T (rs1143634) and serum levels of pentaxin (PTX3) and interleukin -1β (IL-1β) with disease activity of systemic lupus erythematosus patients. Gene Reports 21, pages 100960.
Crossref
Qian Wu, Fan Cao, Jinhui Tao, Xiaomei Li, Song Guo Zheng & Hai-Feng Pan. (2020) Pentraxin 3: A promising therapeutic target for autoimmune diseases. Autoimmunity Reviews 19:12, pages 102584.
Crossref
Qian Wu, Shi-Yang Guan, Yi-Lin Dan, Chan-Na Zhao, Yan-Mei Mao, Li-Na Liu, Xiao-Mei Li, De-Guang Wang & Hai-Feng Pan. (2019) Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis. Biomarkers in Medicine 13:16, pages 1417-1427.
Crossref
Mohammadreza Jafari-Nakhjavani, Amir Ghorbanihaghjo, Elyar Pourghassem, Sima Abediazar, Tala Pourlak & Aida Malekmahdavi. (2019) Serum pentraxin 3 levels in rheumatoid arthritis patients and its association with disease activity. The Egyptian Rheumatologist 41:4, pages 251-254.
Crossref
Giuseppe A. Ramirez, Patrizia Rovere-Querini, Miriam Blasi, Silvia Sartorelli, Maria Chiara Di Chio, Mattia Baldini, Rebecca De Lorenzo, Enrica P. Bozzolo, Roberto Leone, Alberto Mantovani, Angelo A. Manfredi & Enrico Tombetti. (2019) PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases. Frontiers in Immunology 10.
Crossref
Kenzo Hokazono, Fernando Sakata Belizário, Vanessa Portugal, Iara Messias-Reason & Renato Nisihara. (2018) Mannose Binding Lectin and Pentraxin 3 in Patients with Diabetic Retinopathy. Archives of Medical Research 49:2, pages 123-129.
Crossref
S Sahin, A Adrovic, K Barut, S Durmus, R Gelisgen, H Uzun & O Kasapcopur. (2017) Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus. Lupus 26:10, pages 1089-1094.
Crossref
L Wirestam, H Enocsson, T Skogh, M L Eloranta, L Rönnblom, C Sjöwall & J Wetterö. (2017) Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro . Clinical and Experimental Immunology 189:1, pages 83-91.
Crossref
Fahmi AlDhaheri, Talal Almteri, Naji Dwid, Ahd Majdali, Nahed Janoudi & Hani Almoallim. (2017) Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent. American Journal of Case Reports 18, pages 143-147.
Crossref
L. Iaccarino, M. Gatto, M. Zen & A. Doria. 2017. The Heart in Systemic Autoimmune Diseases. The Heart in Systemic Autoimmune Diseases 265 293 .
Barbara Stadler Kahlow, Roberta Petisco, Thelma Larocca Skare, Isabela Goeldner, Renato M. Nisihara & Iara J.T. Messias-Reason. (2016) Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients. International Journal of Cardiology 221, pages 298-301.
Crossref
Xiao-lei Huang, Li Zhang, Yu Duan, Yu-jie Wang & Jing Wang. (2016) Association of Pentraxin 3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Archives of Medical Research 47:3, pages 223-231.
Crossref
Doaa Hussein Zineldeen, Walaa Arafa Keshk, Ahmed Hamza Ghazy & Amal Mohamed El-Barbary. (2015) Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 53:2, pages 240-251.
Crossref
Xu Zhang & Wenyuan Ding. (2016) Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis. Medical Science Monitor 22, pages 2911-2916.
Crossref
Yun Pang, Ying Tan, Yongzhe Li, Jianchun Zhang, Yongbing Guo, Zhiling Guo, Chengying Zhang, Feng Yu & Ming-hui Zhao. (2016) Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis. Medicine 95:3, pages e2520.
Crossref
Thelma L. Skare, Renato Nisihara, Gabriela P. Ramos, Shirley R.R. Utiyama & Iara Messias-Reason. (2015) Pentraxin-3 levels in systemic lupus erythematosus: Association with cumulative damage but not with disease activity. Joint Bone Spine 82:6, pages 466-467.
Crossref
A. Kasperska-Zajac, A. Grzanka, M. Misiolek, B. Mazur & E. Machura. (2015) Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria. Cytokine 76:2, pages 566-568.
Crossref
Silje Stokke Kvistad, Kjell-Morten Myhr, Trygve Holmøy, Jūratė Šaltytė Benth, Stig Wergeland, Antonie G. Beiske, Kristian S. Bjerve, Harald Hovdal, Finn Lilleås, Rune Midgard, Tom Pedersen, Søren J. Bakke, Annika E. Michelsen, Pål Aukrust, Thor Ueland, Jørn V. Sagen & Øivind Torkildsen. (2015) Body mass index influence interferon-beta treatment response in multiple sclerosis. Journal of Neuroimmunology 288, pages 92-97.
Crossref
Helene Bæk Juel, Carsten Faber, Lea Munthe-Fog, Simone Bastrup-Birk, Alexander Lynge Reese-Petersen, Mads Krüger Falk, Amardeep Singh, Torben Lykke Sørensen, Peter Garred & Mogens Holst Nissen. (2015) Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration. PLOS ONE 10:7, pages e0132800.
Crossref
Kárita Cláudia Freitas Lidani, Marcia Holsbach Beltrame, Paola Rosa Luz, Thaisa Lucas Sandri, Renato Mitsunori Nisihara & Iara José de Messias-Reaso. (2015) Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?. International Journal of Cardiology 190, pages 233-235.
Crossref
Roberto Assandri, Marta Monari, Anna Colombo, Alessandra Dossi & Alessandro Montanelli. (2015) Pentraxin 3 Plasma Levels and Disease Activity in Systemic Lupus Erythematosus. Autoimmune Diseases 2015, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.